StockNews.com upgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY – Free Report) from a hold rating to a buy rating in a research note released on Tuesday. A number of other analysts have also recently ...
Dentsply Sirona announced that it initiated a process to evaluate strategic alternatives for its Wellspect Healthcare ...
Hosted on MSN8d
Wells Fargo Initiates Coverage of DENTSPLY SIRONA (XRAY) with Equal-Weight RecommendationFintel reports that on February 14, 2025, Wells Fargo initiated coverage of DENTSPLY SIRONA (NasdaqGS:XRAY) with a ...
The speculation comes as Dentsply ( NASDAQ: XRAY) said Tuesday it started a process to evaluate strategic alternatives for ...
CHARLOTTE, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company has initiated a process to evaluate ...
CHARLOTTE, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company has initiated a process to evaluate ...
Wells Fargo initiated coverage of Dentsply Sirona (XRAY) with an Equal Weight rating and $20 price target The firm does not sees a “clean ...
12d
Dentsply Sirona initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business. Wellspect, a provider of bladder and bowel management care products, has an estimated $2 ...
Fintel reports that on February 14, 2025, Wells Fargo initiated coverage of DENTSPLY SIRONA (NasdaqGS:XRAY) with a Equal-Weight recommendation. As of January 29, 2025, the average one-year price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback